Phox2B Correlates With MYCN and Is a Prognostic Marker for Neuroblastoma Development

Oncology Letters - Greece
doi 10.3892/ol.2015.3088
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

NOTCH4 Is a Novel Prognostic Marker That Correlates With Colorectal Cancer Progression and Prognosis

Journal of Cancer
Oncology
2018English

MYCN Gene Amplification Is a Powerful Prognostic Factor Even in Infantile Neuroblastoma Detected by Mass Screening

British Journal of Cancer
Cancer ResearchOncology
2006English

P53 Is a Direct Transcriptional Target of MYCN in Neuroblastoma

Cancer Research
Cancer ResearchOncology
2010English

Sam68 Is a Novel Marker for Aggressive Neuroblastoma [Corrigendum]

OncoTargets and Therapy
OncologyPharmacology
2014English

Copy Number Gain of MYCN Gene Is a Recurrent Genetic Aberration and Favorable Prognostic Factor in Chinese Pediatric Neuroblastoma Patients

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2013English

Aurora B Kinase Is a Potent and Selective Target in MYCN-driven Neuroblastoma

Oncotarget
Oncology
2015English

Circulating miR-1826 in Plasma Correlates With Circulating Tumor Cells and Is a Prognostic Marker in Colorectal Cancer

Tumor Biology
MedicineCancer Research
2017English

LMO1 Synergizes With MYCN to Promote Neuroblastoma Initiation and Metastasis

Cancer Cell
Cancer ResearchOncologyCell Biology
2017English

Glutathione Biosynthesis Is Upregulated at the Initiation of MYCN-driven Neuroblastoma Tumorigenesis

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy